HCC1937（人乳腺原发性导管癌细胞）

CBP60418

询价

索取STR

产品描述

产品数据库

I. General information
Synonyms:	HCC1937
Background:	This cell line was initiated from a primary ductal carcinoma on October 13, 1995, and took 11.5 months to establish
Species:	Homo sapiens, human
Tissue:	mammary gland; breast/duct
Disease:	TNM stage IIB, grade 3,primary ductal carcinoma
Gender:	female, 23 years adult, Caucasian
Morphology:	epithelial
Growth Mode:	adherent, The line grows as large epithelial cells with a tendency to float at high cell densities
Doubling Time:	N/A
DNA Profile:	Amelogenin: X CSF1PO: 12 D13S317: 13 D16S539: 13,14 D5S818: 12 D7S820: 9,10 THO1: 6 TPOX: 11 vWA: 16,17 Our Cell Line Authentication Service
Culture Medium:	RPMI-1640+20%FBS HCC1937完全培养基，# CBP60418M We strongly suggest to purchase the complete medium from us.
Cryopreservation medium:	90%FBS+10%DMSO
Antigen Expression:	N/A
Receptor Expression:	estrogen receptor, negative progesterone receptor, negative
Oncogene:	BRCA1 (mutated, insertion C at nucleotide 5382), her2/neu -, p53 -
Genes Expressed:	Epithelial glycoprotein 2 (EGP2) cytokeratin 19
Cellular Products:	Epithelial glycoprotein 2 (EGP2) cytokeratin 19
Tumor Formation:	N/A
Comments:	The tumor was classified as TNM Stage IIB, grade 3 BRCA1 analysis revealed that the cell line is homozygous for the BRCA1 5382C mutation, whereas the lymphoblastoid cell line derived from the same patient is heterozygous for the same mutation This mutation was present in two other family members; an identical sister also developed breast cancer The cell line has an acquired mutation of TP53 with wild-type allele loss; an acquired homozygous deletion of the PTEN gene, and loss of heterozygosity at multiple loci known to be involved in the pathogenesis of breast cancer The cells are negative for expression of Her2-neu and for expression of p53. HCC1937 is positive for the epithelial cell specific marker Epithelial Glycoprotein 2 (EGP2) and for cytokeratin 19 The cells are negative for expression of estrogen receptor (ER) and progesterone receptor (PR) An EBV transformed lymphoblastoid cell line (HCC1937BL) from the same patient is available as ATCC CRL-2337 For more information, please contact us (4008-750-250).